Brian Grieb, Oncologist at Tennessee Oncology, shared a post on X:
“Want to see GI data from ASCO 2026? I just posted 2 videos with VuMedi!
- Daraxonrasib in 2L mPDAC
- STRIDE + TACE for HCC
- Zanidatamab for HER2+ mGEA
- EC+FOLFIRI for BRAF V600E mCRC and more!
Other articles on OncoDaily.